This is a preview of subscription content, log in via an institution to check access.
References
Wilson JD, et al., editors. Harrison’ s principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994: 1093–4
Caforio ALP, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996 Oct; 52(4): 515–25
Laws Houghton J. Pericarditis and myocarditis. Which is benign and which isn’ t? Postgrad Med 1992 Feb 1; 91: 273–82
Aretz HT, Billingham ME, Edwards WE, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1–10
Mason JW, O’Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269–75
Williams JF, Bristow MR, Fowler MB, et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995; 92: 2764–84
Drucker NA, Colan SD, Lewis AB, et al. γ-Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252–7
Rights and permissions
About this article
Cite this article
Conventional therapy still the mainstay for myocarditis. Drugs Ther. Perspect 9, 5–7 (1997). https://doi.org/10.2165/00042310-199709050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199709050-00002